LAVA Therapeutics
LVTX
LVTX
19 hedge funds and large institutions have $11.2M invested in LAVA Therapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
57% less capital invested
Capital invested by funds: $26.3M → $11.2M (-$15.1M)
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$949K | |
| 2 | +$88.5K | |
| 3 | +$53.3K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$46.3K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$34K |
Top Sellers
| 1 | -$1.23M | |
| 2 | -$530K | |
| 3 | -$494K | |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$426K |
| 5 |
KI
Kapitalo Investimentos
Sao Paulo,
Brazil
|
-$74.2K |